Clinical Trials Browser

Phase 2 × Unknown × Ado-Trastuzumab Emtansine × Clear all

NCT04197687 2023-12-18

TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

Phase 2 Unknown

Breast Neoplasms

NCT04591431 2023-10-03

ROME

Phase 2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

NCT03418558 2018-10-31

RESCUE

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT03225937 2018-10-30

HERACLES

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms